Corteva, Inc.
CTVABasic MaterialsNASDAQAgricultural Inputs
Scan Results
Daily timeframeCorteva, Inc. operates as a pure-play agriculture company in the United States, Canada, the Middle East, Africa, Europe, Latin America, and Asia. The company carries a $8.31B market cap, placing it firmly in the mid-cap category. The company provides products that protect against weeds, insects, diseases, nematodes, and other pests, as well as supports crop health via nitrogen management and seed-applied technologies.
Market Cap
$8.31B
Beta
—
P/E (TTM)
7.69
P/E (Fwd)
11.00
EPS (TTM)
$1.62
EPS (Fwd)
$1.13
ROE
—
ROA
—
Cash
$1.90B
Total Debt
$4.77B
Free CF
—
52W Change
29.8%
Annual Financials
Cash vs Debt
Where CTVA stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, CTVA finished 3.10% above its 150-day moving average ($12.27) and 5.68% above its 200-day moving average ($11.97). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CTVA overbought or oversold?
At the October 20, 2026 close, CTVA's RSI(14) was 57.7, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, CTVA has $1.90B in cash with $4.77B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Revenue has been relatively flat, moving from $17.45B (2022) to $17.40B (2025).
Investors considering Corteva, Inc. should weigh the typical risks associated with CTVA's sector, size, and financial profile against their own risk tolerance and investment objectives. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CTVA.